Mail

UK markets closed

FTSE 100
7,895.85
+18.80(+0.24%)
FTSE 250
19,391.30
-59.37(-0.31%)
AIM
745.67
+0.38(+0.05%)
GBP/EUR
1.1607
-0.0076(-0.65%)
GBP/USD
1.2370
-0.0068(-0.55%)
Bitcoin GBP
51,671.59
+1,395.98(+2.78%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Interpace Diagnostics Group, Inc. (IDXG)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

1.4500

-0.0200

(-1.36%)

At close: 03:33PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	6.35M
Enterprise value	14.04M
Trailing P/E	5.80
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.16
Price/book (mrq)	10.04
Enterprise value/revenue	0.35
Enterprise value/EBITDA	3.76

Trading information

Stock price history

Beta (5Y monthly)	0.67
52-week change ³	45.00%
S&P500 52-week change ³	20.07%
52-week high ³	3.5400
52-week low ³	0.6203
50-day moving average ³	1.3592
200-day moving average ³	1.2386

Share statistics

Avg vol (3-month) ³	5.71k
Avg vol (10-day) ³	4.38k
Shares outstanding ⁵	4.38M
Implied shares outstanding ⁶	4.32M
Float ⁸	3.35M
% held by insiders ¹	25.99%
% held by institutions ¹	0.00%
Shares short (12 Feb 2021) ⁴	47.35k
Short ratio (12 Feb 2021) ⁴	0.19
Short % of float (12 Feb 2021) ⁴	1.18%
Short % of shares outstanding (12 Feb 2021) ⁴	1.17%
Shares short (prior month 15 Jan 2021) ⁴	68.56k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	15 Jan 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	15 Jan 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	1.99%
Operating margin (ttm)	12.84%

Management effectiveness

Return on assets (ttm)	12.12%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	40.21M
Revenue per share (ttm)	9.31
Quarterly revenue growth (yoy)	23.40%
Gross profit (ttm)	N/A
EBITDA	3.84M
Net income avi to common (ttm)	1.11M
Diluted EPS (ttm)	0.2500
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	3.5M
Total cash per share (mrq)	0.8
Total debt (mrq)	11.19M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.59
Book value per share (mrq)	-14.17

Cash flow statement

Operating cash flow (ttm)	3.79M
Levered free cash flow (ttm)	4.22M